meclofenoxate has been researched along with Idiopathic Parkinson Disease in 3 studies
Meclofenoxate: An ester of DIMETHYLAMINOETHANOL and para-chlorophenoxyacetic acid.
Excerpt | Relevance | Reference |
---|---|---|
" In our previous study, we have shown that chronic administration of rotenone to rats is able to produce motor dysfunction, which increases progressively with rotenone treatment and centrophenoxine (CPH) co-treatment is able to attenuate these motor defects." | 1.35 | Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease. ( Nehru, B; Verma, R, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Parui, A | 1 |
Biswas, S | 1 |
Roy, I | 1 |
Wang, S | 1 |
Zhang, S | 1 |
Xu, C | 1 |
Barron, A | 1 |
Galiano, F | 1 |
Patel, D | 1 |
Lee, YJ | 1 |
Caldwell, GA | 1 |
Caldwell, KA | 1 |
Witt, SN | 1 |
Verma, R | 1 |
Nehru, B | 1 |
3 other studies available for meclofenoxate and Idiopathic Parkinson Disease
Article | Year |
---|---|
Meclofenoxate Inhibits Aggregation of Alpha-synuclein
Topics: alpha-Synuclein; Animals; Dopamine; Humans; Meclofenoxate; Parkinson Disease; Protein Aggregates | 2023 |
Chemical Compensation of Mitochondrial Phospholipid Depletion in Yeast and Animal Models of Parkinson's Disease.
Topics: alpha-Synuclein; Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Carboxy-Lyases; C | 2016 |
Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Cerebellum; Cerebral Cortex; Cytoprotection; Disease Models, Animal; | 2009 |